Mon Apr 15, 2013 5:49pm EDT (Reuters) – Sarepta Therapeutics Inc said U.S. health regulators have asked for additional information on its experimental drug to treat a rare degenerative disease in boys. Sarepta shares fell 9 percent in extended trading after closing at… http://healthmedicinet.com/i/fda-seeks-more-info-on-sareptas-muscular-dystrophy-drug/
